SHREE GANESH REMEDIES
|
The Current P/E Ratio of SHREE GANESH REMEDIES is 30.88.
Share Price | ₹686.7 | Dec 20,2024 |
Market Cap | ₹879.0 Cr | |
Earnings-TTM | ₹28.5 Cr | TTM-Standalone Results |
Price/Earnings | 30.88x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SHREE GANESH REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹879.0 Cr] as on Dec 20,2024
(/) Earnings [ ₹28.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 30.88x ]
Thus, for SHREE GANESH REMEDIES , the investors are currently willing to pay 30.88 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHREE GANESH REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHREE GANESH REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of SHREE GANESH REMEDIES
PE Ratio Performance Analysis for SHREE GANESH REMEDIES
- SHREE GANESH REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 22.17x.
- SHREE GANESH REMEDIES 's operated at median p/e ratio of 26.39x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHREE GANESH REMEDIES 's p/e ratio peaked in Mar2024 at 30.48x.
- SHREE GANESH REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 5.01x.
How does SHREE GANESH REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SHREE GANESH REMEDIES | 28.46 | 30.88 | 879.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.96 | 433,920.0 |
CIPLA LTD | 4,485.22 | 26.51 | 118,917.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.72 | 112,017.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.80 | 97,997.1 |
DIVIS LABORATORIES LTD | 1,836.00 | 84.51 | 155,160.0 |
MANKIND PHARMA LTD | 2,124.86 | 54.43 | 115,661.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 64.50 | 116,231.0 |
LUPIN LTD | 2,651.94 | 36.95 | 97,978.6 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.02 | 72,060.1 |
ABBOTT INDIA LTD | 1,284.66 | 47.37 | 60,853.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHREE GANESH REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.02x |
Max industry PE | 84.51x |
Median industry PE | 36.95x |
Average industry PE | 40.70x |
You may also like the below Video Courses